5-Methylurapidil(CAS: 34661-85-3)

5-Methylurapidil (CAS: 34661-85-3) should comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous labeling. In the European Union, it is subject to the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation. In the United States, the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) have specific guidelines for its handling and registration.

Alternatives to 5-Methylurapidil (CAS: 34661-85-3) include other ureapidil derivatives and related compounds. Common substitutes in synthesis include 4-Methylurapidil and 6-Methylurapidil, which can serve similar functional roles in various chemical processes depending on the specific application.

The market for 5-Methylurapidil (CAS: 34661-85-3) has been growing due to its applications in pharmaceuticals, particularly as a vasodilator. Research trends are focusing on its potential in treating neurological disorders. Prices have remained stable, but there is an emerging trend towards developing more efficient synthesis methods and exploring its therapeutic potential in new indications.

Waste containing 5-Methylurapidil (CAS: 34661-85-3) should be collected in appropriate containers and stored separately from other chemicals. Proper disposal methods include incineration or professional waste disposal services that comply with local and international regulations. Ensure that all safety precautions are followed to prevent environmental contamination and ensure worker safety.